Halozyme Therapeutics is expected to use net earnings to repurchase convertible bonds for 2027 and 2028
2026-09-17 04:33:18
According to CoinMeta, as reported by Reuters, Halozyme Therapeutics is expected to use its net earnings to repurchase its outstanding convertible bonds for 2027 and 2028.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.